Tiger Brokers

Market Chatter: Moderna's Flu Shot Wins Support From FDA Advisers

MT Newswires Live
Jun 19

Moderna's (MRNA) influenza vaccine for adults 50 and older received a recommendation for approval from outside advisers to the US Food and Drug Administration, Bloomberg reported Thursday, citing a unanimous vote by the agency's Vaccines and Related Biological Products Advisory Committee.

The recommendation for the mRNA-based shot is nonbinding, though the FDA typically follows its advisory panels, the report said.

Moderna did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 64.26, Change: +2.46, Percent Change: +3.98

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10